New approach for aggressive breast cancer

An Australian study found that treatment for triple-negative breast cancer, one of the most aggressive and rapidly spreading types, may require measuring levels of the molecule "miR-342," which contributes to promoting the disease's spread when decreased. Research has shown that restoring "miR-342" levels reduced the cancer's metastasis to other organs such as the lungs and bones. Additionally, the drug "Palbociclib" has demonstrated effectiveness in decreasing the metastatic growth of tumors when levels of this molecule are low, potentially opening the door to repurposing existing drugs to treat an especially severe form of breast cancer.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل